Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • mcj96 mcj96 Sep 5, 2013 9:26 AM Flag

    S V N T....is next......The last co Dr Meeker was on the bd of was Penwest Pharma which was acquired for $5/sh

    That's about the price SVNT will fetch in a YE sale........SVNT currently sells for LESS....than 1x 2014 rev estimates.......Does ASTX sell for less than 1x sales ?......My humble recommendation: Use some of your profits to buy SVNT at less than 1x sales.........SVNT's orphan drug Krystexxa is a rare disease therapy that currently sells for only $5,390/dose........Once Krystexxa is priced like peer group rare disease therapies like Acthar, which sells for over $34,000/dose, SVNT's US revs alone will hit about $350 mil......SVNT's breakeven is about $95-$100 mil and SVNT's margins are currently around 80%. Even after giving Duke 8-12% royalties SVNT will still have huge earnings power going forward. Krystexxa 's patent also runs till 2026. Good luck to all.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ASTX
8.495+0.0150(+0.18%)Oct 10 4:00 PMEDT